These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 12791825)

  • 1. Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases.
    Liepe K; Hliscs R; Kropp J; Runge R; Knapp FF; Franke WG
    J Nucl Med; 2003 Jun; 44(6):953-60. PubMed ID: 12791825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow absorbed dose of rhenium-186-HEDP and the relationship with decreased platelet counts.
    de Klerk JM; van Dieren EB; van het Schip AD; Hoekstra A; Zonnenberg BA; van Dijk A; Rutgers DH; Blijham GH; van Rijk PP
    J Nucl Med; 1996 Jan; 37(1):38-41. PubMed ID: 8543998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model-based method for the prediction of whole-body absorbed dose and bone marrow toxicity for 186Re-HEDP treatment of skeletal metastases from prostate cancer.
    Buffa FM; Flux GD; Guy MJ; O'Sullivan JM; McCready VR; Chittenden SJ; Dearnaley DP
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1114-24. PubMed ID: 12761596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer.
    Postema EJ; Börjesson PK; Buijs WC; Roos JC; Marres HA; Boerman OC; de Bree R; Lang M; Munzert G; van Dongen GA; Oyen WJ
    J Nucl Med; 2003 Oct; 44(10):1690-9. PubMed ID: 14530488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoradiographic studies of rhenium-188-hydroxyethylidine diphosphonate in normal skeleton and osteoblastic bone metastases in a rat model of metastatic prostate cancer.
    Liepe K; Geidel HH; Bergmann R; Haase M; Runge R; Kotzerke J
    Nucl Med Commun; 2009 Sep; 30(9):693-9. PubMed ID: 19528873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase 2 study of a high dose of 186Re-HEDP for bone pain palliation in patients with widespread skeletal metastases.
    Pirayesh E; Amoui M; Mirzaee HR; Tabei F; Rakhsha A; Kalantari BA; Shafiei B; Assadi M; Asli IN
    J Nucl Med Technol; 2013 Sep; 41(3):192-6. PubMed ID: 23918612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation dose estimates of 186Re-hydroxyethylidene diphosphonate for palliation of metastatic osseous lesions: an animal model study.
    van Aswegen A; Roodt A; Marais J; Botha JM; Naudé H; Lötter MG; Goedhals L; Doman MJ; Otto AC
    Nucl Med Commun; 1997 Jun; 18(6):582-8. PubMed ID: 9259533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-186 HEDP conditioning therapy in patients with advanced acute lymphoblastic leukemia before allogeneic bone marrow transplantation.
    Döbert N; Martin H; Kranert WT; Menzel C; Klein SA; Mose S; Grünwald F
    Clin Nucl Med; 2003 Sep; 28(9):738-42. PubMed ID: 12972995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhenium-186-labeled hydroxyethylidene diphosphonate dosimetry and dosing guidelines for the palliation of skeletal metastases from androgen-independent prostate cancer.
    Graham MC; Scher HI; Liu GB; Yeh SD; Curley T; Daghighian F; Goldsmith SJ; Larson SM
    Clin Cancer Res; 1999 Jun; 5(6):1307-18. PubMed ID: 10389913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhenium-188(Sn)HEDP for treatment of osseous metastases.
    Maxon HR; Schroder LE; Washburn LC; Thomas SR; Samaratunga RC; Biniakiewicz D; Moulton JS; Cummings D; Ehrhardt GJ; Morris V
    J Nucl Med; 1998 Apr; 39(4):659-63. PubMed ID: 9544677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic radionuclide therapy in pain palliation.
    Liepe K; Runge R; Kotzerke J
    Am J Hosp Palliat Care; 2005; 22(6):457-64. PubMed ID: 16323716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal uptake and soft-tissue retention of 186Re-HEDP and 153Sm-EDTMP in patients with metastatic bone disease.
    Brenner W; Kampen WU; Kampen AM; Henze E
    J Nucl Med; 2001 Feb; 42(2):230-6. PubMed ID: 11216521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation dose estimates in humans for (11)C-acetate whole-body PET.
    Seltzer MA; Jahan SA; Sparks R; Stout DB; Satyamurthy N; Dahlbom M; Phelps ME; Barrio JR
    J Nucl Med; 2004 Jul; 45(7):1233-6. PubMed ID: 15235071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase 1 study of rhenium-186-HEDP in patients with bone metastases originating from breast cancer.
    de Klerk JM; van het Schip AD; Zonnenberg BA; van Dijk A; Quirijnen JM; Blijham GH; van Rijk PP
    J Nucl Med; 1996 Feb; 37(2):244-9. PubMed ID: 8667053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast.
    Minutoli F; Herberg A; Spadaro P; Restifo Pecorella G; Baldari S; Aricò D; Altavilla G; Baldari S
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):355-62. PubMed ID: 17043634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of rhenium-186 after administration of rhenium-186-HEDP to patients with bone metastases.
    de Klerk JM; van Dijk A; van het Schip AD; Zonnenberg BA; van Rijk PP
    J Nucl Med; 1992 May; 33(5):646-51. PubMed ID: 1373767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application.
    Kemerink GJ; Liu X; Kieffer D; Ceyssens S; Mortelmans L; Verbruggen AM; Steinmetz ND; Vanderheyden JL; Green AM; Verbeke K
    J Nucl Med; 2003 Jun; 44(6):947-52. PubMed ID: 12791824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 186Re-HEDP in the treatment of patients with inoperable osteosarcoma.
    Syed R; Bomanji J; Nagabhushan N; Kayani I; Groves A; Waddington W; Cassoni A; Ell PJ
    J Nucl Med; 2006 Dec; 47(12):1927-35. PubMed ID: 17138735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhenium-188-HEDP in the palliative treatment of bone metastases.
    Liepe K; Hliscs R; Kropp J; Grüning T; Runge R; Koch R; Knapp FF; Franke WG
    Cancer Biother Radiopharm; 2000 Jun; 15(3):261-5. PubMed ID: 10941533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of thrombocytopenia in patients treated with rhenium-186-HEDP: guidelines for individual dosage recommendations.
    de Klerk JM; van het Schip AD; Zonnenberg BA; van Dijk A; Stokkel MP; Han SH; Blijham GH; van Rijk PP
    J Nucl Med; 1994 Sep; 35(9):1423-8. PubMed ID: 8071686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.